Continuing Medical Education
Cleveland Clinic Center for Continuing Education
The Center for Continuing Education is committed to sharing a wealth of knowledge with physicians, nurses, and other medical professionals worldwide for more than 80 years. Its objective is to provide high-quality, innovative educational programs that increase the knowledge of health care providers, resulting in improved patient outcomes.
American Society of Clinical Oncology (ASCO)
Featured Abstracts from the 2019 Annual Meeting
- Rivaroxaban Reduces VTE in Patients with Pancreatic Cancer
- Impact of Exercise and Demographics in Breast Cancer Survivors Over Age 65
- Could Immunotherapy Help Cure Cutaneous Squamous Cell Carcinoma?
- Low CD30 Expression in Non-Hodgkin’s Lymphoma Patients Does Not Predict Low Response to Brentuximab Vedotin
- New Renal Cancer Therapy Effective in Higher Risk Groups
- Financial Navigator Support Pays Off for Cancer Patients and Providers
- Optimal Total Dose of Cisplatin for High-Risk Oral Cavity Squamous Cell Carcinoma
American Society for Radiation Oncology (ASTRO)
Featured Abstracts from the 2019 Annual Meeting
- Using Artificial Intelligence to Deliver Personalized Radiation Therapy
- High-Dose Neoadjuvant Radiosurgery for Brain Metastases Appears Safe, Effective in Early Results from Phase 1/2 Study
- Postprostatectomy Prostate-Specific Antigen Kinetics Associated with Recurrence After Salvage Radiation
- Preoperative Pelvic Radiation is Safe, Effective in Patients with IBD and Rectal Cancer
- Stereotactic Body Radiation Therapy: A Promising Approach for Pediatric Patients
- Metabolic Reprogramming: A Promising Approach to Tackling Therapeutic Resistance in Glioblastoma
- Automated Screening Reduces Errors in Radiation Treatment Planning
American Society of Hematology (ASH)
Featured Abstracts from the 2019 Annual Meeting
- Pediatric-inspired Post-remission Chemotherapy Superior to Stem Cell Transplantation for Young Adults with ALL
- Studies' Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials
- Treatment for Myelofibrosis-Associated Anemia on the Horizon
- Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma
- Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma
